secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stoke Therapeutics, Inc. (STOK)
CIK:        0001623526
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001193125-23-170114
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stoke Therapeutics stockholders elect three Class I directors, ratify KPMG, approve charter amendment
--------------------------------------------------------------------------------

- Elected Adrian R. Krainer (23.7M for, 8.0M withheld), Garry E. Menzel (26.0M for, 5.7M withheld), Julie Anne Smith (30.3M for, 1.3M withheld) as Class I directors.
- Ratified KPMG as independent auditor for FY 2023 with 35.5M for, 15.9K against, 987 abstentions.
- Approved amendment to Certificate of Incorporation: 27.0M for, 4.6M against, 4.7K abstentions.
- Broker non-votes of 3.8M shares recorded for director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623526/000119312523170114/0001193125-23-170114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623526/000119312523170114/d520719d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-170114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer